
Join to view full profile
10 Crc3 3330NihBethesda, MD 20892
Phone+1 301-496-1791
Dr. Gress is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineClass of 1975
Certifications & Licensure
MD State Medical License 1978 - 2024
TX State Medical License 1975 - 1999
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1991
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer Start of enrollment: 1996 Jul 12
- Genetic Analysis of Brain Tumors Start of enrollment: 2002 Mar 01
- Interleukin-7 in Treating Patients With Refractory Solid Tumors
Publications & Presentations
PubMed
- 3 citationsPhase 1/2 study of high-dose palifermin for GVHD prophylaxis in patients undergoing HLA-matched unrelated donor HCT.Eduard Schulz, Lauren M Curtis, Noa G Holtzman, Seth M Steinberg, Kaska Wloka
Blood. 2025-08-21 - 1 citationsDisruption of Notch signaling by KGF induces a developmental pause in thymocytes.Ruifeng Teng, Francis A Flomerfelt, Ping Xue, Anjali Chandroth, Constance Tom Noguchi
Frontiers in Immunology. 2025-01-01 - 7 citationsHigh-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention.Noa G Holtzman, Lauren M Curtis, Rachel B Salit, Brian C Shaffer, Filip Pirsl
Blood Advances. 2024-08-27
Journal Articles
- Impact of the 2014 NIH Chronic Graft-Versus-Host Disease Scoring Criteria Modifications Assessed in a Large Cohort of Severely Affected PatientsLauren M Curtis, Galen O Joe, Jacqueline W Mays, Ann Berger, Pamela Stratton, Ronald E Gress, Sandra A Mitchell, Steven Z Pavletic, Kristin Baird, Nature
Grant Support
- Preclinical evaluation of a homing endonuclease gene therapy for adRP in models of P23H retinopathy.UNIVERSITY OF LOUISVILLE2023–2028
- Neurexin Isoforms in Retina Structure and FunctionUNIVERSITY OF LOUISVILLE2025–2027
- Glycine subunit specific inhibition and ganglion cell visual responsesUNIVERSITY OF LOUISVILLE2019–2025
- Etib Clinical TrialsNational Cancer Institute2011
- Etib Clinical Research CoreNational Cancer Institute2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









